Related references
Note: Only part of the references are listed.Wnt/Catenin Signaling in Adult Stem Cell Physiology and Disease
Alexander Ring et al.
STEM CELL REVIEWS AND REPORTS (2014)
CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer
Lia Burkhardt et al.
CANCER RESEARCH (2013)
ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
Changmeng Cai et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers
Antje Krohn et al.
JOURNAL OF PATHOLOGY (2013)
Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion
Guocan Wang et al.
NATURE GENETICS (2013)
Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
Antje Krohn et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
SOXs in human prostate cancer: implication as progression and prognosis factors
Wei-de Zhong et al.
BMC CANCER (2012)
Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades
Jonathan I. Epstein et al.
EUROPEAN UROLOGY (2012)
TMPRSS2-ERG- specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
Jan C. Brase et al.
BMC CANCER (2011)
ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy
Sarah Minner et al.
CLINICAL CANCER RESEARCH (2011)
The genomic complexity of primary human prostate cancer
Michael F. Berger et al.
NATURE (2011)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
FZD4 as a Mediator of ERG Oncogene-Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
Santosh Gupta et al.
CANCER RESEARCH (2010)
SOX9 Elevation in the Prostate Promotes Proliferation and Cooperates with PTEN Loss to Drive Tumor Formation
Martin K. Thomsen et al.
CANCER RESEARCH (2010)
SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion
Hongyun Wang et al.
CANCER RESEARCH (2008)
Sox9 is required for prostate development
Martin K. Thomsen et al.
DEVELOPMENTAL BIOLOGY (2008)
Clinical significance of p53 alterations in surgically treated prostate cancers
Thorsten Schlomm et al.
MODERN PATHOLOGY (2008)
Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer
E. M. Schaeffer et al.
ONCOGENE (2008)
Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis
Jacques Lapointe et al.
CANCER RESEARCH (2007)
SOX9 is required for maintenance of the pancreatic progenitor cell pool
Philip A. Seymour et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells
Hongyun Wang et al.
CANCER RESEARCH (2007)
Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors
Veronique Lefebvre et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming
Kristiina Iljin et al.
CANCER RESEARCH (2006)
SoxE factors function equivalently during neural crest and inner ear development and their activity is regulated by SUMOylation
KM Taylor et al.
DEVELOPMENTAL CELL (2005)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Sox9 is essential for outer root sheath differentiation and the formation of the hair stem cell compartment
VPI Vidal et al.
CURRENT BIOLOGY (2005)
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
ZB Chen et al.
NATURE (2005)
Sex determination:: a tale of two Sox genes
P Koopman
TRENDS IN GENETICS (2005)
Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States
A Jemal et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa
H Akiyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9
R Drivdahl et al.
ONCOGENE (2004)
Transcriptional co-activators CREB-binding protein and p300 regulate chondrocyte-specific gene expression via association with Sox9
M Tsuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The Sox9 transcription factor determines glial fate choice in the developing spinal cord
CC Stolt et al.
GENES & DEVELOPMENT (2003)
Share Paper
